RSLBF Stock Price, Chart, Stats & News

RaySearch Laboratories AB (publ) (RSLBF) is a dividend-paying stock with a current dividend yield of 4.64% as of Aug 13, 2026. It pays $0.8740 per share over the trailing twelve months.
Dividend safety
RSLBF pays out about 126% of earnings, leaving little safety margin.
RSLBF chart
About
RaySearch Laboratories AB (publ) is a global medical technology innovator, dedicated to developing advanced software solutions for cancer treatment. Its flagship product, RayStation, serves as a comprehensive treatment planning platform, integrating sophisticated features such as automated planning, adaptive therapy, multi-criteria optimization, and machine learning. This system ensures swift and precise dose calculations, minimizes exposure to organs-at-risk, and accommodates a wide spectrum of radiation modalities, from cutting-edge proton, carbon ion, and boron neutron capture therapies to conventional VMAT, IMRT, 3D-CRT, virtual simulation, electron beam, stereotactic, and tomotherapy treatments.
Related lists
Similar securities
Based on sector and market capitalization





